TG Therapeutics, Inc. (TGTX): Price and Financial Metrics
TGTX Price/Volume Stats
| Current price | $29.55 | 52-week high | $36.84 |
| Prev. close | $29.14 | 52-week low | $12.84 |
| Day low | $28.62 | Volume | 2,127,800 |
| Day high | $29.68 | Avg. volume | 3,038,018 |
| 50-day MA | $31.40 | Dividend yield | N/A |
| 200-day MA | $22.66 | Market Cap | 4.60B |
TGTX Stock Price Chart Interactive Chart >
TG Therapeutics, Inc. (TGTX) Company Bio
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company was founded in 1993 and is based in New York, New York.
TGTX Price Returns
| 1-mo | -8.23% |
| 3-mo | 21.86% |
| 6-mo | 50.92% |
| 1-year | 96.08% |
| 3-year | 117.76% |
| 5-year | 119.38% |
| YTD | -1.83% |
| 2024 | 76.23% |
| 2023 | 44.38% |
| 2022 | -37.74% |
| 2021 | -63.48% |
| 2020 | 368.65% |
Continue Researching TGTX
Want to see what other sources are saying about Tg Therapeutics Inc's financials and stock price? Try the links below:Tg Therapeutics Inc (TGTX) Stock Price | Nasdaq
Tg Therapeutics Inc (TGTX) Stock Quote, History and News - Yahoo Finance
Tg Therapeutics Inc (TGTX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...